Basit öğe kaydını göster

dc.contributor.authorOkudan, Berna
dc.contributor.authorSeven, Bedri
dc.contributor.authorArican, Pelin
dc.date.accessioned2025-03-28T07:22:46Z
dc.date.available2025-03-28T07:22:46Z
dc.date.issued2024
dc.identifier.issn1573-4056
dc.identifier.issn1875-6603
dc.identifier.urihttps://doi.org/10.2174/0115734056275326231210193544
dc.identifier.urihttps://hdl.handle.net/20.500.12450/5880
dc.description.abstractBackground In order to perform a full surgical resection on non-palpable breast lesions, a current method necessitates correct intraoperative localization. Additionally, because it is an important prognostic factor for these patients, the examination of the lymph node status is crucial.Objective The aim of this study was to evaluate the efficiency of the sentinel node and occult lesion localization (SNOLL) technique in localizing non-palpable breast lesions together with sentinel lymph node (SLN) using a single radiotracer, that is, nanocolloid particles of human serum albumin (NC) labeled with technetium-99m (99mTc).Methods 39 patients were included, each having a single non-palpable breast lesion and clinically no evidence of axillary disease. Patients received 99mTc-NC intratumorally on the same day as surgery under the guidance of ultrasound. Planar and single-photon emission computed tomography/computed tomography lymphoscintigraphy were performed to localize the breast lesion and the SLN. The occult breast lesion and SLN were both localized using a hand-held gamma-probe, which was also utilized to determine the optimal access pathway for surgery. In order to ensure a radical treatment in a single surgical session and reduce the amount of normal tissue that would need to be removed, the surgical field was checked with the gamma probe after the specimen was removed to confirm the lack of residual sources of considerable radioactivity.Results Breast lesions were successfully localized and removed in all patients. Pathological findings revealed breast carcinoma in 11/39 patients (28%) and benign lesions in 28 (72%). Axillary SLNs were detected in 31/39 (79.5%) patients. The metastatic involvement of SLN was only seen in two cases.Conclusion While the identification rate of the SNOLL technique performed with an intratumoral injection of 99mTc-NC as the sole radiotracer in non-palpable breast lesions was great, it was not fully satisfactory in SLNs.en_US
dc.language.isoengen_US
dc.publisherBentham Science Publ Ltden_US
dc.relation.ispartofCurrent Medical Imagingen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectLymphoscintigraphyen_US
dc.subjectNon-palpable breast lesionen_US
dc.subjectRadio-guided surgeryen_US
dc.subjectRadiotraceren_US
dc.subjectSentinel lymph nodeen_US
dc.subjectSNOLLen_US
dc.titleThe Sentinel Node and Occult Lesion Localization (SNOLL) Technique Using a Single Radiopharmaceutical in Non-palpable Breast Lesionsen_US
dc.typearticleen_US
dc.departmentAmasya Üniversitesien_US
dc.identifier.volume20en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.scopus2-s2.0-85186399012en_US
dc.identifier.doi10.2174/0115734056275326231210193544
dc.department-temp[Okudan, Berna; Arican, Pelin] Univ Hlth Sci, Ankara City Hosp, Dept Nucl Med, Ankara, Turkiye; [Seven, Bedri] Univ Amasya, Sabuncuoglu Serefeddin Training & Res Hosp, Dept Nucl Med, TR-05200 Amasya, Turkiyeen_US
dc.identifier.wosWOS:001158057300001en_US
dc.identifier.pmid38284704en_US
dc.snmzKA_WOS_20250328
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster